Your prediction
NGM Biopharmaceuticals Inc Stock
Our community identified positive and negative aspects for NGM Biopharmaceuticals Inc stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the NGM Biopharmaceuticals Inc stock. On the other hand our users think that "Return on equity" could be a problem in the future.
Pros and Cons of NGM Biopharmaceuticals Inc in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target lowered by analysts at B. Riley from $7.00 to $3.50. They now have a "buy" rating on the stock.
Show more
Ratings data for NGM provided by MarketBeat
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Show more
Ratings data for NGM provided by MarketBeat
